Note 3 – Stockholders’ Equity and Share-Based Compensation

Common Stock Issuance

On March 21, 2026, the Company entered into a Purchase Agreement with certain investors. The Company issued and sold an aggregate of 10,000,000 shares of common stock, par value $0.001 per share, at a purchase price of $0.80 per share, resulting in gross proceeds of $8,000.

On September 8, 2025, the Company entered into a Purchase Agreement with certain investors. The Company issued and sold an aggregate of 10,319,727 shares of common stock, par value $0.001 per share, at a purchase price of $1.04 per share, resulting in gross proceeds of $10,733.

Options and Restricted Stock Units

The Company had the following common stock option activity during the thirteen weeks ended April 4, 2026:

The following table summarizes the Company’s restricted stock unit ("RSU") and restricted stock award (“RSA”) activity for the thirteen weeks ended April 4, 2026, and details regarding the awards outstanding and exercisable as of April 4, 2026 (in thousands):

​

During the thirteen weeks ended April 4, 2026, 559 RSUs and RSAs that vested were time-based.

For the thirteen weeks ended April 4, 2026, we recorded compensation costs related to stock options, RSUs and RSAs of $1,749. For the thirteen weeks ended March 29, 2025, we recorded compensation costs related to stock options, RSUs and RSAs of $3,166. As of April 4, 2026, there was unrecognized compensation expense related to stock options, RSUs and RSAs of $5,960 that will be expensed through March 2030.